This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Iakov Lurevich Ustiugov: Innovator in Biotechnology
Introduction
Iakov Lurevich Ustiugov is a notable inventor based in Berezniki, Russia. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies.
Latest Patents
Ustiugov holds a patent for "Anti-PD-1 antibodies, method for producing same and method for using same." This invention relates to isolated monoclonal antibodies, specifically human monoclonal antibodies, that bind to PD-1 with high affinity. The antibodies can be chimeric, humanized, or human antibodies, and may be utilized as medicinal agents in oncology and immuno-oncology. They are designed to treat diseases associated with various cell proliferation or development disorders. The patent also includes methods for producing these antibodies and treating human diseases using them. Ustiugov has 1 patent to his name.
Career Highlights
Throughout his career, Ustiugov has focused on advancing biotechnological solutions that address critical health issues. His work has the potential to impact the treatment of various cancers and related disorders, showcasing his commitment to improving patient outcomes.
Collaborations
Ustiugov has collaborated with notable colleagues, including Olga Vladimirovna Goncharova and Dmitry Valeryevich Korzhavin. These partnerships have likely contributed to the innovative nature of his work and the successful development of his patented technologies.
Conclusion
Iakov Lurevich Ustiugov is a prominent figure in the biotechnology sector, with a focus on developing innovative therapeutic solutions. His contributions, particularly in the realm of anti-PD-1 antibodies, highlight the importance of research and collaboration in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile